A popular arthritis prescription drug called Xeljanz (tofacitinib) has been linked to serious side effects, including blood clots, other cardiovascular issues, and cancer. The US Food and Drug Administration (USDA) issued safety alerts in 2019 and 2021 that indicated Xeljanz could be linked to these side effects, among others. The health concerns are applied to both the 5-mg twice-daily dose and the higher 10-mg strength, and consumers 50+ years of age with arthritis and/or ulcerative colitis are most at risk.
People who have taken this drug are beginning to file claims against Xeljanz’s manufacturer, Pfizer, for failing to warn doctors and patients about the severe health risks associated with their product.
If you or a loved one has taken Xeljanz or Xeljanz XR and are experiencing blood clots, cardiovascular issues or certain forms of cancer, you may be eligible to file a dangerous drug lawsuit against the drug manufacturer for financial compensation. Contact The Guardian Legal Network to find qualified legal representation who can guide you through the legal processing in pursuing a Xeljanz lawsuit.